Group One Trading’s Inhibrx, Inc. Common Stock INBX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-200
Closed -$6.99K 7779
2024
Q1
$6.99K Sell
200
-1,700
-89% -$62K ﹤0.01% 6042
2023
Q4
$72.2K Buy
1,900
+1,800
+1,800% +$38.6K ﹤0.01% 4753
2023
Q3
$1.83K Sell
100
-1,400
-93% -$29.3K ﹤0.01% 7070
2023
Q2
$38.9K Sell
1,500
-11,000
-88% -$257K ﹤0.01% 5471
2023
Q1
$236K Buy
+12,500
New +$291K ﹤0.01% 3516

Other funds holding INBX

Group One Trading's INBX Position: Q1 2024 in Review

Group One Trading sold out of Inhibrx, Inc. Common Stock (INBX) in Q1 2024, closing a stake of 12,666 shares — an estimated $462K sold.

Group One Trading first reported a position in INBX in Q4 2021 and held it in 4 quarters. The position peaked at $481K in Q4 2023. 126 funds tracked by Wall St. Rank hold INBX as of Q1 2024.

  • Group One Trading reported no remaining Inhibrx, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • Group One Trading sold 12,666 Inhibrx, Inc. Common Stock shares in Q1 2024, an estimated $462K.
  • Group One Trading first reported a position in Inhibrx, Inc. Common Stock in Q4 2021 and held it in 4 quarters.
  • Group One Trading's Inhibrx, Inc. Common Stock position peaked at $481K in Q4 2023.
  • 126 funds tracked by Wall St. Rank held Inhibrx, Inc. Common Stock as of Q1 2024.

Based on Group One Trading's 13F filing for Q1 2024, filed 10 May 2024.